Target intelligence / Profile preview

UBE2R2 antisense RNA 1 (UBE2R2-AS1)

Target
UBE2R2-AS1
Molecular classification
long noncoding RNA (lncRNA), long intergenic noncoding RNA (lincRNA), non-protein-coding RNA
01

Overview

UBE2R2 antisense RNA 1 (UBE2R2-AS1) is a long noncoding RNA transcribed in the antisense orientation relative to the UBE2R2 gene. Classified as a long intergenic noncoding RNA, it does not encode a protein but exerts regulatory functions at the RNA level. UBE2R2-AS1 is significantly upregulated in several cancer types, including prostate cancer, where it drives tumor cell proliferation, migration, invasion, epithelial–mesenchymal transition, and suppresses apoptosis. Knockdown of UBE2R2-AS1 has demonstrated suppression of these oncogenic properties, suggesting a potential therapeutic strategy. It is considered a potential biomarker for cancer diagnosis and prognosis and is likely to participate in gene regulatory networks through interaction with key oncogenic and tumor suppressor pathways.

Other names
LINC01251long intergenic non-protein coding RNA 1251UBE2R2-AS1
02

Biological functions

Regulation of cell proliferationPromotion of epithelial–mesenchymal transition (EMT)Regulation of apoptosisCell cycle regulation (notably G0/G1 arrest)
03

Disease associations

Cancer (specifically implicated in prostate cancer, glioma, and liver cancer progression)
04

Biomarkers

Prognostic marker in prostate cancer (expression levels correlate with Gleason score, tumor stage, lymph node metastasis, and survival prognosis)

Beyond the preview

Go deeper on UBE2R2 antisense RNA 1 (UBE2R2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2R2 antisense RNA 1 (UBE2R2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call